FAQs

FAQs

Show All
Where is Metacrine’s corporate headquarters?
Metacrine is headquartered at 3985 Sorrento Valley Blvd., Suite C San Diego, CA 92121
When was the company founded?
Metacrine was incorporated in 2014 and commenced operations in 2015.
When did Metacrine go public?
Metacrine’s initial public offering (IPO) occurred on September 16, 2020.
When is Metacrine’s fiscal year-end?
Metacrine’s fiscal year ends on December 31st.
How is Metacrine’s stock traded?
Metacrine is traded on the NASDAQ Global Market under the ticker symbol MTCR, and its CUSIP number is 59101E103.
Who is Metacrine’s transfer agent?
American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, New York 11219
(800) 937-5449
Who are Metacrine’s independent auditors?

Ernst & Young LLP
4365 Executive Dr, Suite 1600
San Diego, CA 92121

Who is Metacrine’s legal counsel?
Cooley LLP
4401 Eastgate Mall
San Diego, California 92121
(858) 550-6000
Where can I get the latest corporate news releases and financial reports?
Metacrine’s press release archives can be viewed here.
How can I view documents Metacrine has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?
Metacrine’s SEC filings can be viewed here.
Whom should I contact if I have further questions?
You can submit queries to Metacrine’s investor relations department by contacting investors@metacrine.com.